The Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. recently disclosed its position regarding Spire Healthcare Group plc pursuant to Rule 8.3 of the Takeover Code. As of October 3, 2025, Vanguard holds interests in 14,405,163 ordinary shares, representing 3.58% of Spire's relevant securities. The disclosure emphasizes no additional parties to the offer were considered, as it's not a cash offer.

A sale of 2,304 ordinary shares at 2.40 GBP per unit was recorded. No cash-settled or stock-settled derivatives were involved, and no other derivative transactions were noted. Furthermore, no agreements or arrangements relating to options or derivatives exist. Vanguard confirmed there are no indemnity or other dealing arrangements.

The disclosure aims to maintain transparency with regulatory standards as outlined by the Takeover Code. Further information is accessible through regulatory channels.